Madrigal, Clarine Jane .
HRN: 00-98-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2024
CEFUROXIME 500MG (TAB)
11/05/2024
11/11/2024
PO
500mg
Bid
Post Perineorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes